Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance.
about
Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissuesTransforming growth factor-β1 contributes to oxaliplatin resistance in colorectal cancer via epithelial to mesenchymal transition.Individualized predictive signatures for 5-fluorouracil-based chemotherapy in right- and left-sided colon cancer.
P2860
Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Oxaliplatin: pre-clinical pers ...... tion, response and resistance.
@ast
Oxaliplatin: pre-clinical pers ...... tion, response and resistance.
@en
type
label
Oxaliplatin: pre-clinical pers ...... tion, response and resistance.
@ast
Oxaliplatin: pre-clinical pers ...... tion, response and resistance.
@en
prefLabel
Oxaliplatin: pre-clinical pers ...... tion, response and resistance.
@ast
Oxaliplatin: pre-clinical pers ...... tion, response and resistance.
@en
P2093
P2860
P356
P1476
Oxaliplatin: pre-clinical pers ...... tion, response and resistance.
@en
P2093
P2860
P356
10.3332/ECANCER.2009.153
P577
2009-09-24T00:00:00Z